Anaplastic Large Cell Lymphoma Clinical Trials in Rochester
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Recruiting
- Aggressive Non-Hodgkin Lymphoma
- +14 more
- Cholecalciferol
- Laboratory Biomarker Analysis
- Scottsdale, Arizona
- +4 more
2022-03-11
Mar 11, 2022M
Active, not recruiting
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +20 more
- panobinostat
- +6 more
- Scottsdale, Arizona
- +1 more
2022-02-03
Feb 3, 2022M
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +18 more
- everolimus
- +6 more
- Scottsdale, Arizona
- +1 more
2020-09-28
Sep 28, 2020N
Completed
- Anaplastic Large Cell Lymphoma
- +12 more
- Laboratory Biomarker Analysis
- Tipifarnib
- Iowa City, Iowa
- +1 more
2020-04-03
Apr 3, 2020M
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +27 more
- panobinostat
- +3 more
- Scottsdale, Arizona
- +2 more
2020-03-02
Mar 2, 2020M
Completed
- Adult Nasal Type Extranodal NK/T-Cell Lymphoma
- +31 more
- Laboratory Biomarker Analysis
- +3 more
- Rochester, MinnesotaMayo Clinic
2019-11-14
Nov 14, 2019U
Completed
- Anaplastic Large Cell Lymphoma
- +3 more
- prednisone
- +12 more
- Scottsdale, Arizona
- +8 more
2018-05-23
May 23, 2018N
Completed
- Adult Nasal Type Extranodal NK/T-Cell Lymphoma
- +6 more
- Alisertib
- +2 more
- Mobile, Alabama
- +160 more
2016-02-09
Feb 9, 2016N
Terminated
- Adult Grade III Lymphomatoid Granulomatosis
- +56 more
- tanespimycin
- +2 more
- Rochester, MinnesotaMayo Clinic
2014-02-21
Feb 21, 2014